Tango Therapeutics, Inc. · NASDAQ:TNGX

Raymond Debbane reported a 5.30% stake in Tango Therapeutics, Inc. (Schedule 13G)

Event Sep 19, 2025 · Filed Sep 22, 2025

Raymond Debbane reported a 5.30% stake in Tango Therapeutics, Inc., 5,883,188 shares, as a passive investor on Sep 19, 2025. Filed Sep 22, 2025 (Schedule 13G).

Stake
5.30%
Shares
5,883,188
Intent
Passive
What changed
Crossed above 5%
Filed together
8 holders

The filing in full

HolderStakeShares
Invus Public Equities, L.P.4.60%5,082,716
Invus Public Equities Advisors, LLC4.60%5,082,716
Invus Global Management, LLC4.60%5,082,716
Siren, L.L.C.4.60%5,082,716
Avicenna Life Sci Master Fund LP0.70%800,472
Avicenna Life Sci Master GP LLC0.70%800,472
Ulys, L.L.C.0.70%800,472
Raymond Debbane5.30%5,883,188

Source

View original at SEC

Related